Why the study?
Does growth hormone replacement preserve diastolic function and attenuate left ventricular remodeling in senescent rats?
Does growth hormone replacement preserve diastolic function and attenuate left ventricular remodeling in senescent rats?
Long-term growth hormone replacement in senescent rats preserves diastolic function and attenuates ventricular remodeling, suggesting a role for the GH/IGF-1 axis in age-related cardiac decline.
Supports GH/IGF-1 axis exploration in age-related diastolic dysfunction; leaves open translation to human HFpEF therapy.
We tested the hypothesis that long-term growth hormone (GH) replacement in aged rats would preserve diastolic function and attenuate left ventricular remodeling associated with normal aging. Male Brown Norway x F344 rats were randomized to receive twice daily injections of porcine GH (200 microg/injection, subcutaneous) or saline from 24 to 30 months of age. Adult rats (6- to 9-months old) received saline injections throughout the study. Thirty-month-old, saline-treated rats exhibited low levels of insulin-like growth factor 1 (IGF-1), impaired diastolic left ventricular filling (Doppler), increased cardiac angiotensin II (Ang II), reduced plasma Ang II, and increased cardiac collagen. GH administration in old rats restored IGF-1 and diastolic indices to values comparable to those of adults. These effects were associated with reduced cardiac Ang II and attenuations in cardiac collagen. Age-related decreases in GH and IGF-1 may contribute to the decline in diastolic function of aging, in part through alterations in renin-angiotensin system-mediated ventricular remodeling.
No takes yet. Share an insight, caveat, or question.
Groban et al. (2006) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: